CLIMB is a need-based program made possible by a grant to Concordia from the National Science Foundation (NSF). Created in partnership with local biotechnology companies, CLIMB is open to 12 incoming STEM students annually through Fall 2026 who are interested in careers in biotechnology. The program awards scholarships of up to $15,000 per year toward the total cost of attendance and includes opportunities for research experiences and paid internships. Learn more about CLIMB in our frequently asked questions.
Agathos Biologics, established in Fargo in 2021, develops biological systems to facilitate better delivery of therapeutic molecules — including proteins, enzymes, and nucleic acids — directly to cells for applications in biomanufacturing, biologic payload delivery, and cell and gene therapy. Agathos Biologics is on a mission to create ethically acceptable products so that everyone — researchers, physicians, and ultimately patients — can benefit from these novel technologies without compromising their moral beliefs.
Aldevron is a premier manufacturing partner, producing high-quality plasmid DNA, mRNA, proteins, and other key components for the development of vaccines, gene and cell therapies, immunotherapies, and molecular diagnostics. Headquartered in Fargo, with additional locations in Madison, Wisconsin, and Lincoln, Nebraska, Aldevron supports scientists who are developing revolutionary, lifesaving treatments for millions of people.
Genovac is a contract research and manufacturing organization offering advanced antibody discovery, characterization, and biologics production solutions. Its genetic immunization technologies, industry-leading species options, and multiple single B cell screening technologies enable success against the field’s most challenging targets. In addition to its headquarters and labs in Fargo, Genovac operates another scientific and production facility in Freiberg, Germany.